1.
Ismail NA, Hadil FA, Mohamad M. COMPARISON OF DENOSUMAB AND ALENDRONATE EFFICACY AND RELATED DIABETES RISK IN PATIENTS WITH OSTEOPOROSIS. J ASEAN Fed Endocr Soc [Internet]. 2024 Jul. 17 [cited 2026 Apr. 26];39(S1):54. Available from: https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/4573